Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples